Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WHO-recommended Periodic Presumptive Treatment Versus Doxycycline Post-Exposure Prophylaxis for STI Control Among Cisgender Men Who Have Sex With Men in Kenya

NCT06468462 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT06468462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06468462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WHO-recommended Periodic Presumptive Treatment Versus Doxycycline Post-Exposure Prophylaxis for STI Control Among Cisgender Men Who Have Sex With Men in Kenya
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Recruiting
Start date
October 29, 2025
Completion date
April 30, 2029
Enrollment
2,900 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia (male), gonorrhea male, syphilis male